Overview

A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition

Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
To assess the impact of inhalation of insulin on glucose disposition in patients with type 1 diabetes
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Insulin
Insulin, Globin Zinc